| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| May 14, 2024 | May 15, 2024 | Thackray Helen M. Chief R D Officer | Buy | Biocryst Pharmaceuticals Inc | BCRX | $5.86 | $175,800 | +9.93% |
| Apr 03, 2023 | Apr 05, 2023 | Thackray Helen M. Chief R D Officer | Sell | Biocryst Pharmaceuticals Inc | BCRX | $8.29 | $58,030 | -3.27% |
| Dec 15, 2022 | Dec 19, 2022 | Thackray Helen M. Chief R D Officer | Sell | Biocryst Pharmaceuticals Inc | BCRX | $10.89 | $34,031 | -2.29% |
| Apr 01, 2022 | Apr 04, 2022 | Thackray Helen M. Chief R D Officer | Sell | Biocryst Pharmaceuticals Inc | BCRX | $16.2 | $123,120 | -5.28% |
| Dec 08, 2017 | Dec 12, 2017 | Thackray Helen M. SVP Clinical Development CMO | Sell | Glycomimetics Inc | GLYC | $15.01 | $30,020 | -1.33% |
| Sep 18, 2017 | Sep 18, 2017 | Thackray Helen M. SVP Clinical Development CMO | Sell | Glycomimetics Inc | GLYC | $13 | $26,000 | -1.31% |
| May 25, 2017 | May 30, 2017 | Thackray Helen M. SVP Clinical Development CMO | Sell | Glycomimetics Inc | GLYC | $15.57 | $31,140 | -1.29% |
| May 19, 2017 | May 23, 2017 | Thackray Helen M. SVP Clinical Development CMO | Sell | Glycomimetics Inc | GLYC | $12.14 | $24,280 | -1.28% |
| Oct 03, 2016 | Oct 04, 2016 | Thackray Helen M. VP Clinical Development CMO | Sell | Glycomimetics Inc | GLYC | $7 | $28,001 | -2.49% |
| Jul 20, 2016 | Jul 21, 2016 | Thackray Helen M. VP Clinical Development CMO | Sell | Glycomimetics Inc | GLYC | $8 | $16,000 | -1.23% |
| Jul 01, 2016 | Jul 06, 2016 | Thackray Helen M. VP Clinical Development CMO | Sell | Glycomimetics Inc | GLYC | $7 | $153,954 | -11.92% |